ANALYSIS OF URINARY CAFFEINE METABOLITES TO ASSESS BIOTRANSFORMATION ENZYME-ACTIVITIES BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

Authors
Citation
C. Krul et G. Hageman, ANALYSIS OF URINARY CAFFEINE METABOLITES TO ASSESS BIOTRANSFORMATION ENZYME-ACTIVITIES BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 709(1), 1998, pp. 27-34
Citations number
18
Categorie Soggetti
Chemistry Analytical","Biochemical Research Methods
Journal title
Journal of chromatography B. Biomedical sciences and applications
ISSN journal
13872273 → ACNP
Volume
709
Issue
1
Year of publication
1998
Pages
27 - 34
Database
ISI
SICI code
0378-4347(1998)709:1<27:AOUCMT>2.0.ZU;2-C
Abstract
An isocratic high-performance liquid chromatography procedure was deve loped for the analysis of five urinary metabolites of caffeine; caffei ne or 1,3,7-trimethylxanthine (137X), paraxanthine or 1,7-dimethylxant hine (17X), 1,7-dimethylurate (17U), 1-methylxanthine (1X), 1-methylur ate (1U) and 5-acetylamino-6-formylamino-3-methyluraci (AFMU). A stand ardized procedure was used for oral intake of caffeine and for urine c ollection. Conditions for sample storage and preparation were optimize d, resulting in no detectable loss of caffeine metabolites after stora ge of the urine samples for four months. Urine samples were extracted with chloroform-2-propanol (4:1, v/v) and separated on a reversed-phas e column with acetic acid (33%)-tetrahydrofuran-acetonitrile-water (1: 2.5:44:925.5, v/v) as the eluent. Peaks were monitored at 280 nm. Peak heights were measured and the five metabolites were quantified using calibration curves. Cytochrome P4501A2 (CYP1A2) activity was calculate d from the molar ratio (AFMU+1X+1U)/17U, N-acetyltransferase (NAT) fro m the ratio AFMU/1X, XO from the ratio 1U/1X+1U and cytochrome P4502A6 (CYP2A6) from the ratio 17U/(17U+17X+1U+1X+AFMU). The inter-assay coe fficients of variation ranged from 1.7% for 17U to 5.7% for 1X. The in tra-individual variation in metabolite ratios determined in two people , with intervals of a few days to several weeks between measurements, ranged from 2.1% for XO to 11.0% for CYP2A6. Using this procedure, met abolic ratios were determined for four groups of subjects; healthy, no n-smoking females using oral contraceptives (OC users, n=5) and non-us ers (n=5), healthy nonsmoking males (n=9) and children (n=7). Results found in this study were comparable to results reported in the literat ure for subjects with similar characteristics. A significantly higher CYP1A2 ratio was found for males (4.87+/-0.47) compared to females (3. 62+/-0.91; p=0.005, Mann-Whitney). For the other enzyme activities, no significant differences were found between the groups of subjects in this study. (C) 1998 Elsevier Science B.V.